nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycopyrrolate—Intestinal obstruction—Vincristine—muscle cancer	0.0224	0.0224	CcSEcCtD
Glycopyrrolate—Nystagmus—Vincristine—muscle cancer	0.0213	0.0213	CcSEcCtD
Glycopyrrolate—Musculoskeletal chest pain—Doxorubicin—muscle cancer	0.0165	0.0165	CcSEcCtD
Glycopyrrolate—Pain in extremity—Vincristine—muscle cancer	0.0111	0.0111	CcSEcCtD
Glycopyrrolate—Cardiac arrest—Vincristine—muscle cancer	0.0105	0.0105	CcSEcCtD
Glycopyrrolate—Urinary retention—Vincristine—muscle cancer	0.0105	0.0105	CcSEcCtD
Glycopyrrolate—Dehydration—Vincristine—muscle cancer	0.0103	0.0103	CcSEcCtD
Glycopyrrolate—Pneumonia—Dactinomycin—muscle cancer	0.0096	0.0096	CcSEcCtD
Glycopyrrolate—Anaphylactoid reaction—Etoposide—muscle cancer	0.00926	0.00926	CcSEcCtD
Glycopyrrolate—Nystagmus—Doxorubicin—muscle cancer	0.00896	0.00896	CcSEcCtD
Glycopyrrolate—Dysuria—Vincristine—muscle cancer	0.00894	0.00894	CcSEcCtD
Glycopyrrolate—Erectile dysfunction—Vincristine—muscle cancer	0.00881	0.00881	CcSEcCtD
Glycopyrrolate—Pneumonia—Vincristine—muscle cancer	0.00857	0.00857	CcSEcCtD
Glycopyrrolate—Cardiac arrest—Etoposide—muscle cancer	0.00852	0.00852	CcSEcCtD
Glycopyrrolate—Sweating—Vincristine—muscle cancer	0.00817	0.00817	CcSEcCtD
Glycopyrrolate—Flushing—Dactinomycin—muscle cancer	0.00795	0.00795	CcSEcCtD
Glycopyrrolate—Ageusia—Doxorubicin—muscle cancer	0.0079	0.0079	CcSEcCtD
Glycopyrrolate—Hypoaesthesia—Vincristine—muscle cancer	0.00761	0.00761	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Vincristine—muscle cancer	0.00756	0.00756	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Vincristine—muscle cancer	0.00752	0.00752	CcSEcCtD
Glycopyrrolate—Urethral disorder—Vincristine—muscle cancer	0.0075	0.0075	CcSEcCtD
Glycopyrrolate—Erythema—Dactinomycin—muscle cancer	0.00746	0.00746	CcSEcCtD
Glycopyrrolate—Cystitis noninfective—Methotrexate—muscle cancer	0.00722	0.00722	CcSEcCtD
Glycopyrrolate—Cystitis—Methotrexate—muscle cancer	0.00714	0.00714	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Vincristine—muscle cancer	0.0071	0.0071	CcSEcCtD
Glycopyrrolate—Pneumonia—Etoposide—muscle cancer	0.00695	0.00695	CcSEcCtD
Glycopyrrolate—Infestation NOS—Etoposide—muscle cancer	0.00691	0.00691	CcSEcCtD
Glycopyrrolate—Infestation—Etoposide—muscle cancer	0.00691	0.00691	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Vincristine—muscle cancer	0.0069	0.0069	CcSEcCtD
Glycopyrrolate—Mental disorder—Vincristine—muscle cancer	0.0067	0.0067	CcSEcCtD
Glycopyrrolate—Bladder pain—Methotrexate—muscle cancer	0.00669	0.00669	CcSEcCtD
Glycopyrrolate—Atrioventricular block—Doxorubicin—muscle cancer	0.0066	0.0066	CcSEcCtD
Glycopyrrolate—Ventricular tachycardia—Doxorubicin—muscle cancer	0.0064	0.0064	CcSEcCtD
Glycopyrrolate—Injection site reaction—Doxorubicin—muscle cancer	0.00636	0.00636	CcSEcCtD
Glycopyrrolate—Cystitis noninfective—Doxorubicin—muscle cancer	0.00625	0.00625	CcSEcCtD
Glycopyrrolate—Cystitis—Doxorubicin—muscle cancer	0.00618	0.00618	CcSEcCtD
Glycopyrrolate—Hypoaesthesia—Etoposide—muscle cancer	0.00617	0.00617	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Etoposide—muscle cancer	0.00612	0.00612	CcSEcCtD
Glycopyrrolate—Agitation—Vincristine—muscle cancer	0.00612	0.00612	CcSEcCtD
Glycopyrrolate—Oedema—Dactinomycin—muscle cancer	0.00609	0.00609	CcSEcCtD
Glycopyrrolate—Urethral disorder—Etoposide—muscle cancer	0.00608	0.00608	CcSEcCtD
Glycopyrrolate—Infection—Dactinomycin—muscle cancer	0.00605	0.00605	CcSEcCtD
Glycopyrrolate—Bladder pain—Doxorubicin—muscle cancer	0.00579	0.00579	CcSEcCtD
Glycopyrrolate—Convulsion—Vincristine—muscle cancer	0.00577	0.00577	CcSEcCtD
Glycopyrrolate—Flushing—Etoposide—muscle cancer	0.00575	0.00575	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Etoposide—muscle cancer	0.00575	0.00575	CcSEcCtD
Glycopyrrolate—Hypertension—Vincristine—muscle cancer	0.00575	0.00575	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Etoposide—muscle cancer	0.00559	0.00559	CcSEcCtD
Glycopyrrolate—Anaphylactoid reaction—Methotrexate—muscle cancer	0.00555	0.00555	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Vincristine—muscle cancer	0.00544	0.00544	CcSEcCtD
Glycopyrrolate—Oedema—Vincristine—muscle cancer	0.00544	0.00544	CcSEcCtD
Glycopyrrolate—Infection—Vincristine—muscle cancer	0.0054	0.0054	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Vincristine—muscle cancer	0.00533	0.00533	CcSEcCtD
Glycopyrrolate—Dysgeusia—Etoposide—muscle cancer	0.00528	0.00528	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Vincristine—muscle cancer	0.00526	0.00526	CcSEcCtD
Glycopyrrolate—Fatigue—Dactinomycin—muscle cancer	0.00525	0.00525	CcSEcCtD
Glycopyrrolate—Pain—Dactinomycin—muscle cancer	0.0052	0.0052	CcSEcCtD
Glycopyrrolate—Irritability—Methotrexate—muscle cancer	0.00512	0.00512	CcSEcCtD
Glycopyrrolate—Mood swings—Methotrexate—muscle cancer	0.00508	0.00508	CcSEcCtD
Glycopyrrolate—Hypotension—Vincristine—muscle cancer	0.00508	0.00508	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Dactinomycin—muscle cancer	0.00501	0.00501	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00498	0.00498	CcSEcCtD
Glycopyrrolate—Insomnia—Vincristine—muscle cancer	0.00492	0.00492	CcSEcCtD
Glycopyrrolate—Abdominal pain—Dactinomycin—muscle cancer	0.00481	0.00481	CcSEcCtD
Glycopyrrolate—Body temperature increased—Dactinomycin—muscle cancer	0.00481	0.00481	CcSEcCtD
Glycopyrrolate—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.0048	0.0048	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Vincristine—muscle cancer	0.00469	0.00469	CcSEcCtD
Glycopyrrolate—Fatigue—Vincristine—muscle cancer	0.00469	0.00469	CcSEcCtD
Glycopyrrolate—Convulsion—Etoposide—muscle cancer	0.00468	0.00468	CcSEcCtD
Glycopyrrolate—Hypertension—Etoposide—muscle cancer	0.00466	0.00466	CcSEcCtD
Glycopyrrolate—Constipation—Vincristine—muscle cancer	0.00465	0.00465	CcSEcCtD
Glycopyrrolate—Pain—Vincristine—muscle cancer	0.00465	0.00465	CcSEcCtD
Glycopyrrolate—Pain in extremity—Doxorubicin—muscle cancer	0.00465	0.00465	CcSEcCtD
Glycopyrrolate—Affect lability—Doxorubicin—muscle cancer	0.00457	0.00457	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00456	0.00456	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Dactinomycin—muscle cancer	0.00448	0.00448	CcSEcCtD
Glycopyrrolate—Abdominal discomfort—Methotrexate—muscle cancer	0.00445	0.00445	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Vincristine—muscle cancer	0.00445	0.00445	CcSEcCtD
Glycopyrrolate—Confusional state—Etoposide—muscle cancer	0.00444	0.00444	CcSEcCtD
Glycopyrrolate—Cardiac arrest—Doxorubicin—muscle cancer	0.00442	0.00442	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Etoposide—muscle cancer	0.0044	0.0044	CcSEcCtD
Glycopyrrolate—Mood swings—Doxorubicin—muscle cancer	0.0044	0.0044	CcSEcCtD
Glycopyrrolate—Infection—Etoposide—muscle cancer	0.00438	0.00438	CcSEcCtD
Glycopyrrolate—Asthenia—Dactinomycin—muscle cancer	0.00437	0.00437	CcSEcCtD
Glycopyrrolate—Dysuria—Methotrexate—muscle cancer	0.00434	0.00434	CcSEcCtD
Glycopyrrolate—Dehydration—Doxorubicin—muscle cancer	0.00432	0.00432	CcSEcCtD
Glycopyrrolate—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00431	0.00431	CcSEcCtD
Glycopyrrolate—Tachycardia—Etoposide—muscle cancer	0.0043	0.0043	CcSEcCtD
Glycopyrrolate—Abdominal pain—Vincristine—muscle cancer	0.0043	0.0043	CcSEcCtD
Glycopyrrolate—Body temperature increased—Vincristine—muscle cancer	0.0043	0.0043	CcSEcCtD
Glycopyrrolate—Skin disorder—Etoposide—muscle cancer	0.00428	0.00428	CcSEcCtD
Glycopyrrolate—Erectile dysfunction—Methotrexate—muscle cancer	0.00427	0.00427	CcSEcCtD
Glycopyrrolate—Dry skin—Doxorubicin—muscle cancer	0.00426	0.00426	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Etoposide—muscle cancer	0.00426	0.00426	CcSEcCtD
Glycopyrrolate—Pneumonia—Methotrexate—muscle cancer	0.00416	0.00416	CcSEcCtD
Glycopyrrolate—Nasopharyngitis—Doxorubicin—muscle cancer	0.00416	0.00416	CcSEcCtD
Glycopyrrolate—Infestation—Methotrexate—muscle cancer	0.00414	0.00414	CcSEcCtD
Glycopyrrolate—Drowsiness—Methotrexate—muscle cancer	0.00414	0.00414	CcSEcCtD
Glycopyrrolate—Infestation NOS—Methotrexate—muscle cancer	0.00414	0.00414	CcSEcCtD
Glycopyrrolate—Hypotension—Etoposide—muscle cancer	0.00412	0.00412	CcSEcCtD
Glycopyrrolate—Abdominal distension—Doxorubicin—muscle cancer	0.00404	0.00404	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Vincristine—muscle cancer	0.00401	0.00401	CcSEcCtD
Glycopyrrolate—Sweating—Methotrexate—muscle cancer	0.00397	0.00397	CcSEcCtD
Glycopyrrolate—Somnolence—Etoposide—muscle cancer	0.00392	0.00392	CcSEcCtD
Glycopyrrolate—Epistaxis—Methotrexate—muscle cancer	0.0039	0.0039	CcSEcCtD
Glycopyrrolate—Asthenia—Vincristine—muscle cancer	0.0039	0.0039	CcSEcCtD
Glycopyrrolate—Vomiting—Dactinomycin—muscle cancer	0.00387	0.00387	CcSEcCtD
Glycopyrrolate—Rash—Dactinomycin—muscle cancer	0.00384	0.00384	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Etoposide—muscle cancer	0.0038	0.0038	CcSEcCtD
Glycopyrrolate—Fatigue—Etoposide—muscle cancer	0.0038	0.0038	CcSEcCtD
Glycopyrrolate—Pain—Etoposide—muscle cancer	0.00377	0.00377	CcSEcCtD
Glycopyrrolate—Constipation—Etoposide—muscle cancer	0.00377	0.00377	CcSEcCtD
Glycopyrrolate—Dysuria—Doxorubicin—muscle cancer	0.00376	0.00376	CcSEcCtD
Glycopyrrolate—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00373	0.00373	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Methotrexate—muscle cancer	0.00367	0.00367	CcSEcCtD
Glycopyrrolate—Urethral disorder—Methotrexate—muscle cancer	0.00364	0.00364	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Etoposide—muscle cancer	0.00363	0.00363	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Doxorubicin—muscle cancer	0.00362	0.00362	CcSEcCtD
Glycopyrrolate—Nausea—Dactinomycin—muscle cancer	0.00361	0.00361	CcSEcCtD
Glycopyrrolate—Pneumonia—Doxorubicin—muscle cancer	0.0036	0.0036	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Etoposide—muscle cancer	0.0036	0.0036	CcSEcCtD
Glycopyrrolate—Dizziness—Vincristine—muscle cancer	0.0036	0.0036	CcSEcCtD
Glycopyrrolate—Infestation NOS—Doxorubicin—muscle cancer	0.00358	0.00358	CcSEcCtD
Glycopyrrolate—Infestation—Doxorubicin—muscle cancer	0.00358	0.00358	CcSEcCtD
Glycopyrrolate—Drowsiness—Doxorubicin—muscle cancer	0.00358	0.00358	CcSEcCtD
Glycopyrrolate—Urticaria—Etoposide—muscle cancer	0.0035	0.0035	CcSEcCtD
Glycopyrrolate—Abdominal pain—Etoposide—muscle cancer	0.00348	0.00348	CcSEcCtD
Glycopyrrolate—Body temperature increased—Etoposide—muscle cancer	0.00348	0.00348	CcSEcCtD
Glycopyrrolate—Urinary tract infection—Doxorubicin—muscle cancer	0.00348	0.00348	CcSEcCtD
Glycopyrrolate—Vomiting—Vincristine—muscle cancer	0.00346	0.00346	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Methotrexate—muscle cancer	0.00345	0.00345	CcSEcCtD
Glycopyrrolate—Sweating—Doxorubicin—muscle cancer	0.00343	0.00343	CcSEcCtD
Glycopyrrolate—Rash—Vincristine—muscle cancer	0.00343	0.00343	CcSEcCtD
Glycopyrrolate—Dermatitis—Vincristine—muscle cancer	0.00342	0.00342	CcSEcCtD
Glycopyrrolate—Headache—Vincristine—muscle cancer	0.00341	0.00341	CcSEcCtD
Glycopyrrolate—Epistaxis—Doxorubicin—muscle cancer	0.00338	0.00338	CcSEcCtD
Glycopyrrolate—Sinusitis—Doxorubicin—muscle cancer	0.00336	0.00336	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Methotrexate—muscle cancer	0.00335	0.00335	CcSEcCtD
Glycopyrrolate—Mental disorder—Methotrexate—muscle cancer	0.00325	0.00325	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Etoposide—muscle cancer	0.00324	0.00324	CcSEcCtD
Glycopyrrolate—Malnutrition—Methotrexate—muscle cancer	0.00323	0.00323	CcSEcCtD
Glycopyrrolate—Erythema—Methotrexate—muscle cancer	0.00323	0.00323	CcSEcCtD
Glycopyrrolate—Nausea—Vincristine—muscle cancer	0.00323	0.00323	CcSEcCtD
Glycopyrrolate—Rhinitis—Doxorubicin—muscle cancer	0.00322	0.00322	CcSEcCtD
Glycopyrrolate—Hypoaesthesia—Doxorubicin—muscle cancer	0.0032	0.0032	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Doxorubicin—muscle cancer	0.00318	0.00318	CcSEcCtD
Glycopyrrolate—Dysgeusia—Methotrexate—muscle cancer	0.00317	0.00317	CcSEcCtD
Glycopyrrolate—Asthenia—Etoposide—muscle cancer	0.00316	0.00316	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Doxorubicin—muscle cancer	0.00316	0.00316	CcSEcCtD
Glycopyrrolate—Urethral disorder—Doxorubicin—muscle cancer	0.00315	0.00315	CcSEcCtD
Glycopyrrolate—Pruritus—Etoposide—muscle cancer	0.00312	0.00312	CcSEcCtD
Glycopyrrolate—Vision blurred—Methotrexate—muscle cancer	0.00305	0.00305	CcSEcCtD
Glycopyrrolate—Flushing—Doxorubicin—muscle cancer	0.00298	0.00298	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Doxorubicin—muscle cancer	0.00298	0.00298	CcSEcCtD
Glycopyrrolate—Dizziness—Etoposide—muscle cancer	0.00291	0.00291	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Doxorubicin—muscle cancer	0.0029	0.0029	CcSEcCtD
Glycopyrrolate—Mental disorder—Doxorubicin—muscle cancer	0.00282	0.00282	CcSEcCtD
Glycopyrrolate—Convulsion—Methotrexate—muscle cancer	0.0028	0.0028	CcSEcCtD
Glycopyrrolate—Vomiting—Etoposide—muscle cancer	0.0028	0.0028	CcSEcCtD
Glycopyrrolate—Malnutrition—Doxorubicin—muscle cancer	0.0028	0.0028	CcSEcCtD
Glycopyrrolate—Erythema—Doxorubicin—muscle cancer	0.0028	0.0028	CcSEcCtD
Glycopyrrolate—Rash—Etoposide—muscle cancer	0.00278	0.00278	CcSEcCtD
Glycopyrrolate—Dermatitis—Etoposide—muscle cancer	0.00277	0.00277	CcSEcCtD
Glycopyrrolate—Headache—Etoposide—muscle cancer	0.00276	0.00276	CcSEcCtD
Glycopyrrolate—Flatulence—Doxorubicin—muscle cancer	0.00276	0.00276	CcSEcCtD
Glycopyrrolate—Tension—Doxorubicin—muscle cancer	0.00275	0.00275	CcSEcCtD
Glycopyrrolate—Dysgeusia—Doxorubicin—muscle cancer	0.00274	0.00274	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00273	0.00273	CcSEcCtD
Glycopyrrolate—Nervousness—Doxorubicin—muscle cancer	0.00272	0.00272	CcSEcCtD
Glycopyrrolate—Confusional state—Methotrexate—muscle cancer	0.00266	0.00266	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Methotrexate—muscle cancer	0.00264	0.00264	CcSEcCtD
Glycopyrrolate—Vision blurred—Doxorubicin—muscle cancer	0.00264	0.00264	CcSEcCtD
Glycopyrrolate—Infection—Methotrexate—muscle cancer	0.00262	0.00262	CcSEcCtD
Glycopyrrolate—Nausea—Etoposide—muscle cancer	0.00262	0.00262	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Methotrexate—muscle cancer	0.00259	0.00259	CcSEcCtD
Glycopyrrolate—Agitation—Doxorubicin—muscle cancer	0.00257	0.00257	CcSEcCtD
Glycopyrrolate—Skin disorder—Methotrexate—muscle cancer	0.00256	0.00256	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Methotrexate—muscle cancer	0.00255	0.00255	CcSEcCtD
Glycopyrrolate—Palpitations—Doxorubicin—muscle cancer	0.00247	0.00247	CcSEcCtD
Glycopyrrolate—Hypotension—Methotrexate—muscle cancer	0.00246	0.00246	CcSEcCtD
Glycopyrrolate—Convulsion—Doxorubicin—muscle cancer	0.00242	0.00242	CcSEcCtD
Glycopyrrolate—Hypertension—Doxorubicin—muscle cancer	0.00242	0.00242	CcSEcCtD
Glycopyrrolate—Insomnia—Methotrexate—muscle cancer	0.00239	0.00239	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00237	0.00237	CcSEcCtD
Glycopyrrolate—Somnolence—Methotrexate—muscle cancer	0.00235	0.00235	CcSEcCtD
Glycopyrrolate—Dry mouth—Doxorubicin—muscle cancer	0.00233	0.00233	CcSEcCtD
Glycopyrrolate—Dyspepsia—Methotrexate—muscle cancer	0.00232	0.00232	CcSEcCtD
Glycopyrrolate—Confusional state—Doxorubicin—muscle cancer	0.0023	0.0023	CcSEcCtD
Glycopyrrolate—Oedema—Doxorubicin—muscle cancer	0.00228	0.00228	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Doxorubicin—muscle cancer	0.00228	0.00228	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00228	0.00228	CcSEcCtD
Glycopyrrolate—Fatigue—Methotrexate—muscle cancer	0.00227	0.00227	CcSEcCtD
Glycopyrrolate—Infection—Doxorubicin—muscle cancer	0.00227	0.00227	CcSEcCtD
Glycopyrrolate—Pain—Methotrexate—muscle cancer	0.00226	0.00226	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Doxorubicin—muscle cancer	0.00224	0.00224	CcSEcCtD
Glycopyrrolate—Tachycardia—Doxorubicin—muscle cancer	0.00223	0.00223	CcSEcCtD
Glycopyrrolate—Skin disorder—Doxorubicin—muscle cancer	0.00222	0.00222	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Doxorubicin—muscle cancer	0.00221	0.00221	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Methotrexate—muscle cancer	0.00217	0.00217	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Methotrexate—muscle cancer	0.00216	0.00216	CcSEcCtD
Glycopyrrolate—Hypotension—Doxorubicin—muscle cancer	0.00213	0.00213	CcSEcCtD
Glycopyrrolate—Urticaria—Methotrexate—muscle cancer	0.0021	0.0021	CcSEcCtD
Glycopyrrolate—Body temperature increased—Methotrexate—muscle cancer	0.00209	0.00209	CcSEcCtD
Glycopyrrolate—Abdominal pain—Methotrexate—muscle cancer	0.00209	0.00209	CcSEcCtD
Glycopyrrolate—Insomnia—Doxorubicin—muscle cancer	0.00207	0.00207	CcSEcCtD
Glycopyrrolate—Somnolence—Doxorubicin—muscle cancer	0.00203	0.00203	CcSEcCtD
Glycopyrrolate—Dyspepsia—Doxorubicin—muscle cancer	0.00201	0.00201	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00197	0.00197	CcSEcCtD
Glycopyrrolate—Fatigue—Doxorubicin—muscle cancer	0.00197	0.00197	CcSEcCtD
Glycopyrrolate—Pain—Doxorubicin—muscle cancer	0.00195	0.00195	CcSEcCtD
Glycopyrrolate—Constipation—Doxorubicin—muscle cancer	0.00195	0.00195	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Methotrexate—muscle cancer	0.00194	0.00194	CcSEcCtD
Glycopyrrolate—Asthenia—Methotrexate—muscle cancer	0.00189	0.00189	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Doxorubicin—muscle cancer	0.00188	0.00188	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00187	0.00187	CcSEcCtD
Glycopyrrolate—Pruritus—Methotrexate—muscle cancer	0.00187	0.00187	CcSEcCtD
Glycopyrrolate—Urticaria—Doxorubicin—muscle cancer	0.00181	0.00181	CcSEcCtD
Glycopyrrolate—Body temperature increased—Doxorubicin—muscle cancer	0.00181	0.00181	CcSEcCtD
Glycopyrrolate—Abdominal pain—Doxorubicin—muscle cancer	0.00181	0.00181	CcSEcCtD
Glycopyrrolate—Dizziness—Methotrexate—muscle cancer	0.00174	0.00174	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Doxorubicin—muscle cancer	0.00168	0.00168	CcSEcCtD
Glycopyrrolate—Vomiting—Methotrexate—muscle cancer	0.00168	0.00168	CcSEcCtD
Glycopyrrolate—Rash—Methotrexate—muscle cancer	0.00166	0.00166	CcSEcCtD
Glycopyrrolate—Dermatitis—Methotrexate—muscle cancer	0.00166	0.00166	CcSEcCtD
Glycopyrrolate—Headache—Methotrexate—muscle cancer	0.00165	0.00165	CcSEcCtD
Glycopyrrolate—Asthenia—Doxorubicin—muscle cancer	0.00164	0.00164	CcSEcCtD
Glycopyrrolate—Pruritus—Doxorubicin—muscle cancer	0.00162	0.00162	CcSEcCtD
Glycopyrrolate—Nausea—Methotrexate—muscle cancer	0.00157	0.00157	CcSEcCtD
Glycopyrrolate—Dizziness—Doxorubicin—muscle cancer	0.00151	0.00151	CcSEcCtD
Glycopyrrolate—Vomiting—Doxorubicin—muscle cancer	0.00145	0.00145	CcSEcCtD
Glycopyrrolate—Rash—Doxorubicin—muscle cancer	0.00144	0.00144	CcSEcCtD
Glycopyrrolate—Dermatitis—Doxorubicin—muscle cancer	0.00144	0.00144	CcSEcCtD
Glycopyrrolate—Headache—Doxorubicin—muscle cancer	0.00143	0.00143	CcSEcCtD
Glycopyrrolate—Nausea—Doxorubicin—muscle cancer	0.00136	0.00136	CcSEcCtD
